Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9626 posts found.

Andreotti

Lamberto Andreotti new head of Bristol-Myers Squibb

March 4, 2010 Research and Development, Sales and Marketing BMS, appointment, research and development, sales and marketing

Bristol-Myers Squibb has appointed Lamberto Andreotti its new chief executive with effect from 4 May, succeeding James Cornelius who will …
Appointment

Stem cell therapy helps diabetes limb problems

March 3, 2010 Research and Development ReNeuron, diabetes, stem cell

Stem cell therapy aimed at restoring blood flow to damaged limbs in people with diabetes has shown promise, according to UK …
News

Funds keep Archimedes Pharma buoyant

March 3, 2010 Research and Development Archimedes, funding

Archimedes Pharma has completed the biggest fundraising by a private European biotech in 15 years by securing £65 million. The …
News

UK hit hard as AstraZeneca reveals R&D cuts

March 3, 2010 Research and Development AstraZeneca, job cuts

Nearly 3,500 R&D jobs will be affected at AstraZeneca in the coming months as the pharmaceutical giant exits discovery research …
News

Kinex Pharmaceuticals appoints Rudolf Kwan

March 2, 2010 Research and Development Kinex Pharmaceuticals, appointment, research and development

Dr Rudolf Kwan has joined Buffalo, US-based  Kinex Pharmaceuticals as chief medical officer. He will be responsible for the design …
Appointment

Clinical research news in brief

March 2, 2010 Research and Development Community Research, Evotec, FDA, INC Research, Kendle, Parexel

A round-up of recent developments in the clinical research arena includes proposals from the FDA on reporting falsified trials, Kendle’s …
News

Quotient Bioresearch Presents Comprehensive Drug Development Capabilities via New Company Website

March 1, 2010 Research and Development

Quotient Bioresearch partners its clients with a unique offering of leading-edge technologies and services for all stages of early drug …
News
Press release
Merck KGaA

Merck KGaA invests in bioresearch and bioproduction

March 1, 2010 Manufacturing and Production, Research and Development Biochemistry, Merck KGaA, Merck Serono, Millipore, laboratory services

Merck KGaA has bought US life sciences company Millipore Corporation in a $7.2 billion deal to expand its chemicals business. …
News

Single orphan document will simplify process for industry

March 1, 2010 Research and Development EMA, FDA, Orphan

The FDA and European Medicines Agency are to simplify the regulatory process for orphan medicines by agreeing to accept a …
News
ICON headquarters

ICON sees revenues rise in 2009

March 1, 2010 Research and Development CRO, ICON

Contract research organisation ICON saw its revenues increase 3% to $888 million last year and says it is “positive, though …
News

Quotient Clinical receives MHRA Supplementary Accreditation

February 26, 2010 Research and Development Quotient

 This is one of the highest levels of accreditation in Europe and confirms that Quotient Clinical is qualified to perform …
Feature
Case study
Press release

Government ups the ante in dementia research

February 26, 2010 Research and Development Alzheimer's, dementia

The government has attempted to ‘up the ante’ in dementia research by convening a ministerial group comprising charities, scientists, research …
News

Avastin study in ovarian cancer meets primary endpoint

February 25, 2010 Research and Development Cancer, avastin, ovarian

Preliminary results from a trial of Roche’s Avastin in advanced ovarian cancer suggest that the drug lengthens progression-free survival when …
News

Sanofi’s breast cancer candidate tipped for future success

February 25, 2010 Research and Development, Sales and Marketing BSI-201, Sanofi-Aventis, breast cancer

A Sanofi-Aventis drug currently in phase III has been predicted as a future blockbuster in breast cancer treatment. Sanofi’s BSI-201 …
News

Avastin fails in phase III study

February 24, 2010 Research and Development Roche, avastin, gastric cancer, stomach cancer

Roche’s Avastin does not help patients with a severe form of stomach cancer to live longer, according to the results …
News
The Gateway to Local Adoption Series

Latest content

Closing the immunisation gap: partnership working that delivered at scale

June 5, 2026

Phase 2 study explores imaging approach for interstitial lung disease

June 5, 2026

Laverock secures funding for gene-control platform development

June 4, 2026

LifeArc and Elpida partner to advance gene therapies for ultra-rare childhood diseases

June 3, 2026

Well Pharmacy and Alzheimer’s Society launch dementia partnership

June 2, 2026